SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:kth-279171"
 

Search: onr:"swepub:oai:DiVA.org:kth-279171" > Duchenne Muscular D...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Duchenne Muscular Dystrophy : recent advances in protein biomarkers and the clinical application

Al-Khalili Szigyarto, Cristina (author)
KTH,Systembiologi,Science for Life Laboratory, SciLifeLab
 (creator_code:org_t)
2020-07-26
2020
English.
In: Expert Review of Proteomics. - : Informa UK Limited. - 1478-9450 .- 1744-8387. ; 17:5, s. 365-375
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • Introduction Early biomarker discovery studies have praised the value of their emerging results, predicting an unprecedented impact on health care. Biomarkers are expected to provide tests with increased specificity and sensitivity compared to existing measures, improve the decision-making process, and accelerate the development of therapies. For rare disorders, like Duchenne Muscular Dystrophy (DMD) such biomarkers can assist the development of therapies, therefore also helping to find a cure for the disease. Area covered State-of-the-art technologies have been used to identify blood biomarkers for DMD and efforts have been coordinated to develop and promote translation of biomarkers for clinical practice. Biomarker translation to clinical practice is however, adjoined by challenges related to the complexity of the disease, involving numerous biological processes, and the limited sample resources. This review highlights the current progress on the development of biomarkers, describing the proteomics technologies used, the most promising findings and the challenges encountered. Expert opinion Strategies for effective use of samples combined with orthogonal proteomics methods for protein quantification are essential for translating biomarkers to the patient's bed side. Progress is achieved only if strong evidence is provided that the biomarker constitutes a reliable indicator of the patient's health status for a specific context of use.

Keyword

Protein biomarkers
biomarker validation
Duchenne Muscular Dystrophy
rare diseases
serum
plasma

Publication and Content Type

ref (subject category)
for (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Al-Khalili Szigy ...
Articles in the publication
Expert Review of ...
By the university
Royal Institute of Technology

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view